Search - tctmd.com

Displaying 301 - 320 of 2446

Sort: Relevancy | Date

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

August 15, 2024

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

August 13, 2024

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 09, 2024

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

August 05, 2024

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

August 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

August 01, 2024

Semaglutide May Ease Tobacco Use, Study Suggests

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

August 01, 2024

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

TCTMD’s Top 10 Most Popular Stories for July 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2024

July 31, 2024

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

Schoolwide Intervention May Improve Obesity Outcomes Over Time

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

News Daily News

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

July 25, 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

News Conference News SCCT 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

July 22, 2024

Incidental CAC Tied to Worse Outcomes in Systemic Inflammatory Diseases

News Conference News SCCT 2024

Incidental CAC Tied to Worse Outcomes in Systemic Inflammatory Diseases

July 21, 2024

FDA to Add New Diversity Requirements for Certain Clinical Studies

News Daily News

FDA to Add New Diversity Requirements for Certain Clinical Studies

July 15, 2024

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

News Daily News

Stressors From All Sides Impact Women’s CV Risk, Review Asserts

July 10, 2024

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

News Daily News

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

July 10, 2024

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.